In silico evaluation of Marchantin C as a potential alpha-glucosidase inhibitor for diabetes and obesity with molecular docking and ADMET profiling

Metabolic disorders, such as obesity and diabetes, necessitate the discovery of novel and effective enzyme inhibitors. Alpha-glucosidase is a therapeutic target for controlling postprandial hyperglycemia. The inhibition potential of Marchantin C, was evaluated against human intestinal α-glucosidase using integrated in silico approaches in this study. Molecular docking simulations performed via AutoDock Vina revealed that Marchantin C possesses an exceptional binding affinity of -8.6 kcal/mol, significantly outperforming the clinical reference drugs acarbose (-6.3 kcal/mol) and miglitol (-5.0 kcal/mol). Notably, the binding energy of Marchantin C was also superior to the native-fixed pose of acarbose (-7.8 kcal/mol), confirming its high thermodynamic stability within the catalytic pocket. Interaction analysis demonstrated that Marchantin C effectively targets the enzyme's catalytic centre, forming crucial bonds with residues Asp203 and Thr205, supplemented by Pi-Pi stacking with Trp406. Furthermore, ADMET and pharmacokinetic profiling via SwissADME indicated that Marchantin C exhibits high gastrointestinal absorption and a favourable drug-likeness profile, adhering to Lipinski's Rule of Five. Visualisation through BOILED-Egg and bioavailability radar plots further supported its potential as an orally active agent. These findings provide strong computational evidence that Marchantin C is a promising natural lead compound for managing obesity and type 2 diabetes, warranting further in vivo investigations.

Authors

Institutions

Publication Details

Journal
Anatolian Bryology
Published
2026-11-13
DOI
https://doi.org/10.26672/anatolianbryology.1982646
Primary Topic
Natural Antidiabetic Agents Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

In silico evaluation of Marchantin C as a potential alpha-glucosidase inhibitor for diabetes and obesity with molecular docking and ADMET profiling

Ergin Murat Altuner
3 links
Anatolian Bryology
Natural Antidiabetic Agents Studies
article

In silico evaluation of Marchantin C as a potential alpha-glucosidase inhibitor for diabetes and obesity with molecular docking and ADMET profiling

Ergin Murat Altuner
article en

Abstract

Metabolic disorders, such as obesity and diabetes, necessitate the discovery of novel and effective enzyme inhibitors. Alpha-glucosidase is a therapeutic target for controlling postprandial hyperglycemia. The inhibition potential of Marchantin C, was evaluated against human intestinal α-glucosidase using integrated in silico approaches in this study. Molecular docking simulations performed via AutoDock Vina revealed that Marchantin C possesses an exceptional binding affinity of -8.6 kcal/mol, significantly outperforming the clinical reference drugs acarbose (-6.3 kcal/mol) and miglitol (-5.0 kcal/mol). Notably, the binding energy of Marchantin C was also superior to the native-fixed pose of acarbose (-7.8 kcal/mol), confirming its high thermodynamic stability within the catalytic pocket. Interaction analysis demonstrated that Marchantin C effectively targets the enzyme's catalytic centre, forming crucial bonds with residues Asp203 and Thr205, supplemented by Pi-Pi stacking with Trp406. Furthermore, ADMET and pharmacokinetic profiling via SwissADME indicated that Marchantin C exhibits high gastrointestinal absorption and a favourable drug-likeness profile, adhering to Lipinski's Rule of Five. Visualisation through BOILED-Egg and bioavailability radar plots further supported its potential as an orally active agent. These findings provide strong computational evidence that Marchantin C is a promising natural lead compound for managing obesity and type 2 diabetes, warranting further in vivo investigations.

Anatolian BryologyVol. 12(2)
Kastamonu University (TR)
Good health and well-being
Natural Antidiabetic Agents Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon